Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

James Webb

Chief Commercial Officer

EpiDisease SL

Valencia, Spain

3 profile visits

EpiDisease SL, a biotechnology company founded in 2014, develops in vitro tools that allow data-based clinical decision making for complex human conditions based on epigenetics and genetics technologies.

My organisation

EpiDisease SL

EpiDisease SL

SME

Valencia, Spain

At EpiDisease SL, we focus on advancing public health through innovative digital solutions and epidemiological research. Our team is dedicated to providing cutting-edge tools and insights that help organizations understand and combat disease outbreaks effectively. By leveraging data analytics and technology, we empower stakeholders to make informed decisions that enhance community health outcomes. We are committed to fostering collaboration and sharing knowledge to navigate the challenges of global health together.
Read more

About me

James holds a Master’s degree in Molecular Biology alongside an Executive MBA specialising in entrepreneurship. With 22 years of expertise and experience in commercial roles within the biotechnology sector, he has a proven track record of global success in launching diagnostic and therapeutics solutions in niche markets.

Social media

Marketplace (3)

  • Partnership

    HIST — HistSHOCK & HistSHOCK CDx

    First histone-based IVD test to diagnose sepsis (Sn77%, Sp89%) & predict septic shock. 450-patient RWE trial finsished 1Q26. CE-IVD Q1 2027. CDx for Phase II anti-histone therapy on-going. $16B+ SAM. Seeking pharma co-development & out-licensing partners.

    Author

    James Webb

    Chief Commercial Officer at EpiDisease SL

    Valencia, Spain

  • Partnership

    AgingMETRIX

    Simplified epigenetic biological age test via saliva, based on ELOVL2 methylation (R²=0.83). Non-invasive, results in 21 days. Available DTC in Spain. Seeking distribution, licensing & integration partners in wellness & longevity platforms.

    Author

    James Webb

    Chief Commercial Officer at EpiDisease SL

    Valencia, Spain